Altered Tumor Necrosis Factor Response in Neurologic Postacute SARS-CoV-2 Syndrome
Allan-Blitz LT, Goodrich J, Hu H, Akbari O, Klausner JD. Altered Tumor Necrosis Factor Response in Neurologic Postacute SARS-CoV-2 Syndrome. J Interferon Cytokine Res. 2023 Jul;43(7):307-313. doi: 10.1089/jir.2023.0051. Epub 2023 Jun 29. PMID: 37384921; PMCID: PMC10354723.
What Long COVID Prevention Strategies Suggest About Its Pathophysiology
Allan-Blitz LT, Hu H, Klausner JD. What Long COVID Prevention Strategies Suggest About Its Pathophysiology. Open Forum Infect Dis. 2023 Sep 8;10(10):ofad466. doi: 10.1093/ofid/ofad466. PMID: 37822557; PMCID: PMC10563786.
Unique immune and inflammatory cytokine profiles may define long COVID syndrome
Allan-Blitz LT, Akbari O, Kojima N, Saavedra E, Chellamuthu P, Denny N, MacMullan MA, Hess V, Shacreaw M, Brobeck M, Turner F, Slepnev VI, Ibrayeva A, Klausner JD. Unique immune and inflammatory cytokine profiles may define long COVID syndrome. Clin Exp Med. 2023 Oct;23(6):2925-2930. doi: 10.1007/s10238-023-01065-6. Epub 2023 Apr 16. PMID: 37061998; PMCID: PMC10105906.
Plasma proteomics show altered inflammatory and mitochondrial proteins in patients with neurologic symptoms of post-acute sequelae of SARS-CoV-2 infection
Hanson BA, Visvabharathy L, Orban ZS, Jimenez M, Batra A, Liotta EM, DeLisle RK, Klausner JD, Cohen P, Padhye AS, Tachas G, Koralnik IJ. Plasma proteomics show altered inflammatory and mitochondrial proteins in patients with neurologic symptoms of post-acute sequelae of SARS-CoV-2 infection. Brain Behav Immun. 2023 Nov;114:462-474. doi: 10.1016/j.bbi.2023.08.022. Epub 2023 Sep 11. PMID: 37704012; PMCID: PMC10718560.